ARTELO BIOSCIENCES, INC. cotiza a 3.11 USD y tiene una capitalización bursátil de $2M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, develops and commercializes therapeutics that target lipid-signaling pathways in the United States. The company's product candidate pipeline includes ART27.13, a synthetic dual cannabinoid G protein-coupled receptor agonist, which is in Phase 1b/2a c…
| Periodo | 2026-02 | 2025-11 | 2025-08 | 2025-05 |
|---|---|---|---|---|
| Real | $-1.08 | $-107.19 | $-151.47 | $-116.64 |
| Estimado | $-42.39 | $-22.14 | $-113.13 | $-21.06 |
| Sorpresa | +97.5% | -384.1% | -33.9% | -453.8% |
| Métrica | ARTL | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | — | -40.4% | — |
| ROA | -459.8% | -32.0% | -427.8% |
| Current Ratio | 0.17 | 2.84 | -2.67 |
| Debt / Equity | — | 0.28 | — |